Quarterly Consolidated Balance Sheet

JCR Pharmaceuticals Co.,Ltd. - Filing #7728294

Concept As at
2017-12-31
As at
2017-03-31
Quarterly consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
5,030,000,000 JPY
5,509,000,000 JPY
Securities
1,135,000,000 JPY
300,000,000 JPY
Merchandise and finished goods
2,292,000,000 JPY
1,757,000,000 JPY
Work in process
1,500,000,000 JPY
1,591,000,000 JPY
Raw materials and supplies
5,934,000,000 JPY
4,389,000,000 JPY
Other
1,181,000,000 JPY
1,332,000,000 JPY
Current assets
23,491,000,000 JPY
20,315,000,000 JPY
Non-current assets
Property, plant and equipment
11,131,000,000 JPY
11,387,000,000 JPY
Property, plant and equipment
Buildings and structures
Buildings and structures, net
4,827,000,000 JPY
4,938,000,000 JPY
Land
3,882,000,000 JPY
3,882,000,000 JPY
Construction in progress
72,000,000 JPY
31,000,000 JPY
Other
Other, net
2,349,000,000 JPY
2,536,000,000 JPY
Intangible assets
Intangible assets
120,000,000 JPY
67,000,000 JPY
Investments and other assets
4,819,000,000 JPY
4,614,000,000 JPY
Investments and other assets
Investment securities
3,927,000,000 JPY
3,587,000,000 JPY
Other
915,000,000 JPY
1,049,000,000 JPY
Allowance for doubtful accounts
-22,000,000 JPY
-22,000,000 JPY
Non-current assets
16,070,000,000 JPY
16,069,000,000 JPY
Assets
39,561,000,000 JPY
36,385,000,000 JPY
Liabilities
Current liabilities
Notes and accounts payable - trade
320,000,000 JPY
700,000,000 JPY
Short-term borrowings
5,101,000,000 JPY
1,493,000,000 JPY
Income taxes payable
703,000,000 JPY
69,000,000 JPY
Other
2,377,000,000 JPY
1,844,000,000 JPY
Current liabilities
8,840,000,000 JPY
4,706,000,000 JPY
Non-current liabilities
Long-term borrowings
2,500,000,000 JPY
2,713,000,000 JPY
Retirement benefit liability
616,000,000 JPY
582,000,000 JPY
Other
350,000,000 JPY
458,000,000 JPY
Non-current liabilities
3,790,000,000 JPY
4,092,000,000 JPY
Liabilities
12,631,000,000 JPY
8,799,000,000 JPY
Net assets
Shareholders' equity
Share capital
9,061,000,000 JPY
9,061,000,000 JPY
Capital surplus
10,954,000,000 JPY
10,964,000,000 JPY
Retained earnings
9,883,000,000 JPY
8,149,000,000 JPY
Treasury shares
-4,055,000,000 JPY
-1,486,000,000 JPY
Shareholders' equity
25,844,000,000 JPY
26,689,000,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
652,000,000 JPY
569,000,000 JPY
Foreign currency translation adjustment
158,000,000 JPY
149,000,000 JPY
Remeasurements of defined benefit plans
-70,000,000 JPY
-103,000,000 JPY
Valuation and translation adjustments
740,000,000 JPY
616,000,000 JPY
Share acquisition rights
345,000,000 JPY
279,000,000 JPY
Non-controlling interests
0 JPY
0 JPY
Net assets
26,930,000,000 JPY
27,585,000,000 JPY
Liabilities and net assets
39,561,000,000 JPY
36,385,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.